๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Hefei
Clinical trial register · China

Clinical Trials in Hefei, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Hefei 55 Fuyang 5 Wuhan 3 Wuhu 2 Beijing 2
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Anhui Provincial Hospital55 Merck Sharp & Dohme LLC36 Anhui Medical University29 AstraZeneca27 Chia Tai Tianqing Pharmaceutical Group Co., Ltd.25 Clear sponsor filter
Site location
Hefei55 Fuyang5 Wuhan3 Wuhu2 Beijing2
All 19 locations
Target enrolment
to

Trials with a site in Hefei

55 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Perioperative Adebrelimab for Locally Advanced Cervical Cancer
NCT07811375Locally Advanced Cervical Cancer
Anhui Provincial Hospital
Phase 2
35
Hefei
2026-10-01
Recruiting
Oral Zinc Supplementation Combined With Targeted Immunotherapy for Unresectable or Advanced Hepatocellular Carcinoma
NCT07793695Hepatocellular Carcinoma
Anhui Provincial Hospital
Phase 2
60
Hefei
2026-09-16
Not yet open
Postoperative ctHPV-DNA for Recurrence Prediction and Adjuvant Treatment Decision-Making in Cervical Cancer
NCT07782697Cervical Cancer, HPV DNA
Anhui Provincial Hospital
Observational
580
Hefei
2026-09
Recruiting
China Metastatic Liver Cancer Clinical Registry Cohort Database
NCT07602504Liver Metastases, Metastases to Liver, Liver Cancer, Neoplasms
Anhui Provincial Hospital
Observational
2,000
Bengbu, Hefei, Qingdao
2026-06-01
Not yet open
Effects of Recombinant Human Growth Hormone in Elderly Patients With Moderate to Severe Acute Brain Injury (GH-ABI-RCT)
NCT07481656Acute Brain Injuries, Moderate to Severe Traumatic Brain Injury
Anhui Provincial Hospital
Phase 4
160
Hefei
2026-04-10
Not yet open
Simultaneous Vs Staged VPS and CP :A Multi-cnter RCT.
NCT07462676Ventriculoperitoneal Shunt (VPS), Cranioplasty
Anhui Provincial Hospital
Not applicable
300
Hefei
2026-04-01
Recruiting
Anti CD19 Gene Therapy for B-cell Lymphoma
NCT07211048B-cell Lymphoma
Anhui Provincial Hospital
Not applicable
18
Hefei
2026-03-20
Recruiting
The Treatment of Liver Injury After Liver Resection With Polyene Phosphatidylcholine
NCT07150624Hepatocellular Carcinoma (HCC), Liver Diseases
Anhui Provincial Hospital
Phase 4
96
Hefei
2025-11-10
Recruiting
Reconstruction Kinetics of ฮณฮด T Cells After Unrelated Cord Blood Transplantation
NCT07782684Hematologic Disease and Disorders
Anhui Provincial Hospital
Observational
100
Hefei
2025-10-09
Recruiting
A Multi Tumor, Open Phase I Clinical Study on the Progression of First-line Anti-tumor Therapy Using Cardonizumab Combined With Pulsed Low-dose Rate External Irradiation (PLDR)
NCT06232083Lung Cancer, Esophageal Cancer, Cervical Cancer
Anhui Provincial Hospital
Phase 1
20
Hefei
2025-09-01
Not yet open
Discovery of HPV T Cell Epitopes and Development of Multi-epitope Vaccines
NCT07077980Cervical Cancer
Anhui Provincial Hospital
Observational
50
Hefei
2025-09-01
Recruiting
Safety and Efficacy of Metabolically Armed Tumor-lnfiltrating Lymphocytes (Meta10-TIL) for the Treatment of Advanced Solid Tumors
NCT07106814Advanced Solid Tumors
Anhui Provincial Hospital
Phase EARLY_PHASE1
36
Hefei
2025-08-29
Recruiting
Anti CD19/BCMA CAR Gene Therapy for Autoimmune Diseases
NCT07121777Autoimmune Diseases
Anhui Provincial Hospital
Not applicable
18
Hefei
2025-08-25
Not yet open
Definitive Proton Radiotherapy Combined With Chemotherapy and Immunotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Phase I Clinical Study
NCT07034118Esophageal Carcinoma
Anhui Provincial Hospital
Phase 1
23
Hefei
2025-08-01
Recruiting
Intravenous Infusion of Umbilical Cord Blood as an Adjunctive Treatment for Alzheimer's Disease
NCT07208344Alzheimer Disease (AD)
Anhui Provincial Hospital
Phase EARLY_PHASE1
30
Hefei
2025-07-31
Recruiting
CAR-T Cells Therapy for Patients With Autoimmune Diseases
NCT07052565Autoimmune Diseases
Anhui Provincial Hospital
Not applicable
18
Hefei
2025-07-20
Recruiting
Efficacy and Safety Study of Romiplostim N01 for Cancer Treatment-induced Thrombocytopenia (CTIT) in the Treatment of Leukemia
NCT06898983Cancer Treatment-induced Thrombocytopenia (CTIT)
Anhui Provincial Hospital
Phase 2
97
Hefei
2025-07-14
Recruiting
Effect of Stem Cell Infusion Time on aGVHD in Patients With Hematological Malignancies Post UCBT
NCT07047456Acute Graft Versus Host Disease
Anhui Provincial Hospital
Phase 3
134
Hefei
2025-07-11
Recruiting
Ivonescimab Plus Short-Course Hypofractionated Radiotherapy as Second-Line Therapy for Esophageal Squamous Cell Carcinoma
NCT07188103Esophageal Squamous Cell Carcinoma
Anhui Provincial Hospital
Phase 2
37
Hefei
2025-07-01
Recruiting
Safety and Efficacy of Metabolically Armed BCMA CAR-T Cells (Meta10-BCMA) in the Treatment of r/r Plasma Cell Neoplasms Clinical Research
NCT07085559Multiple Myeloma (MM), Plasma Cell Leukemia (PCL), AL Amyloidosis (AL)
Anhui Provincial Hospital
Phase EARLY_PHASE1
36
Hefei
2025-06-23
Recruiting
Artificial Intelligence for Pathology Diagnosis and Prognosis Prediction of Lung Nodule Using Smartphone Photos
NCT07098884Artificial Intelligence, Lung Nodule
Anhui Provincial Hospital
Observational
600
Hefei, Suzhou, Ningbo
2025-06-01
Recruiting
Intravenous Autologous CD19 CAR-T Cells for R/ R MM, B-ALL, and B-Cell Lymphoma
NCT06961669Lymphoblastic Leukemia, Relapsed or Refractory Multiple Myeloma (RRMM)
Anhui Provincial Hospital
Not applicable
18
Hefei
2025-04-16
Recruiting
China Liver Cancer Clinical Registry Cohort Database (HEAL)
NCT06777485Liver Cancer
Anhui Provincial Hospital
Observational
10,000
Anqing, Bengbu, Bozhou, Chizhou, Chuzhou, Fuyang, Hefei, Huaibei
2025-01-01
Recruiting
Ultrasensitive SERS Platform With Highly Efficient Enrichment of Analyte for Screening and Diagnosis of Epithelial Ovarian Cancer
NCT06640348Ovarian Cancer, Epithelial
Anhui Provincial Hospital
Observational
70
Hefei
2025-01-01
Recruiting
Head-to-head Comparison of [18F]AlF-PSMA-N5 With [18F]F-DCFPyL PET/CT in PCa Diagnosis, Recurrence, and Metastasis
NCT06756334Prostate Cancer, PET/CT
Anhui Provincial Hospital
Phase EARLY_PHASE1
30
Hefei
2024-12-19
Recruiting
The Addictive Diagnostic Value of Apparent Diffusion Coefficients to bpMRI in the Diagnosis of Prostate Cancer
NCT06737588Prostate Cancer
Anhui Provincial Hospital
Observational
600
Hefei, Wuhu
2024-12-01
Recruiting
Romiplostim N01 for Platelet Recovery in Adult Hematologic Malignancies Patients Undergoing UCBT
NCT06693791Platelet Recovery After Umbilical Cord Blood Transplantation
Anhui Provincial Hospital
Phase 2
34
Hefei
2024-12-01
Recruiting
The Safety and Efficacy of Coenzyme I for Injection in Promoting Hematopoietic Recovery of Patients After sUCBT
NCT06558253Hematopoietic Recovery
Anhui Provincial Hospital
Phase 1
12
Hefei
2024-11-29
Recruiting
Exploring the Efficacy and Safety of Tislelizumab in Combination With S-1 in the Treatment of Patients With Postoperative Recurrent High-risk Intrahepatic Cholangiocarcinoma
NCT06664021Intrahepatic Cholangiocarcinoma
Anhui Provincial Hospital
Phase 2
60
Fuyang, Hefei
2024-11-16
Recruiting
Lusutrombopag Combined With Recombinant Human Thrombopoietin for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Destined to Undergo Elective Invasive Surgery
NCT06673498Thrombocytopenia
Anhui Provincial Hospital
Phase 2
60
Fuyang, Hefei
2024-11-10
Recruiting
Comparison of 5.0T and 3.0T Biparametric Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer
NCT06612047Prostate Cancer
Anhui Provincial Hospital
Observational
150
Hefei
2024-10-08
Recruiting
Telpegfilgrastim Injection to Reduce the Risk of Neutropenia in Patients With Solid Tumor
NCT07096479Chemotherapy-induced Neutropenia
Anhui Provincial Hospital
Observational
318
Hefei
2024-08-15
Recruiting
Adjuvant Treatment of Patients With High Risk of Recurrent Hepatocellular Carcinoma With Donafenib in Combination With Envafolimab
NCT06498622Hepatocellular Carcinoma
Anhui Provincial Hospital
Phase 2
45
Fuyang, Hefei
2024-07-20
Recruiting
Hypofractionated Radiotherapy Combined with Immunotherapy for Limited-stage Small-cell Lung Cancer
NCT06527898Small-cell Lung Cancer
Anhui Provincial Hospital
Phase 1/2
45
Hefei
2024-07-01
Not yet open
Effectiveness and Safety of a Single-Center Clinical Study on a CD25 Monoclonal Antibody-Containing GVHD Prophylaxis Scheme to Reduce the Incidence of Severe Acute GVHD After Umbilical Cord Blood Transplantation for Malignant Hematologic Diseases
NCT06480630Acute Graft Versus Host Disease, Malignant Hematologic Neoplasm
Anhui Provincial Hospital
Phase 2
39
Hefei
2024-07-01
Recruiting
Local Liver Treatment for Multi-organ Colorectal Cancer Metastases
NCT06449937Metastatic Colorectal Carcinoma, Multi-organ Metastatic Colorectal Cancer, Metastatic Malignant Neoplasm in the Liver
Anhui Provincial Hospital
Not applicable
130
Chuzhou, Fuyang, Hefei, Maโ€™anshan, Wuhu
2024-07
By invitation
A Clinical Study to Evaluate CUD005 Injection in Patients with Liver Cirrhosis
NCT06671275Cirrhosis Liver
Anhui Provincial Hospital
Phase 1
9
Hefei
2024-06-21
Active, closed
Mesenteric Lymph Node Metastasis and Nutritional Status After Bowel Resection for Ovarian Cancer
NCT06527001Progression-Free Survival, Overall Survival, Nutrition Aspect of Cancer
Anhui Provincial Hospital
Observational
300
Hefei
2024-06-16
Recruiting
Sulfamethoxazole Prophylaxis Duration After Renal Transplantation
NCT07231770Fever, Chest Tightness
Anhui Provincial Hospital
Not applicable
450
Hefei
2024-05-28
Not yet open
A Study on the Safety and Preliminary Efficacy of NK042 in the Treatment of Malignant Ascites
NCT06415500Gynecologic Cancer
Anhui Provincial Hospital
Phase 1
9
Hefei
2024-05-06
Recruiting
Cervical Cancer Susceptible Population Classification
NCT06405945Cervical Cancer Susceptible Population Classification
Anhui Provincial Hospital
Observational
10,000
Hefei
2024-05-01
Recruiting
The Efficacy and Safety of Desensitation Regimen for Patients With High Titers of Anti-HLA Antibodies Prior to Allo-HSCT
NCT06362967High Titers of Anti-HLA Antibody (MFI โ‰ฅ5000)
Anhui Provincial Hospital
Phase 2
30
Hefei
2024-05-01
Recruiting
Effect of Stem Cell Infusion Time on aGVHD in Patients With Nonmalignant Hematologic Diseases
NCT06294691Acute Graft-versus-host Disease
Anhui Provincial Hospital
Phase 3
198
Hefei, Beijing, Zhengzhou, Wuhan, Shanghai, Hangzhou
2024-03-15
Recruiting
The Safety and Efficacy of RD06-03 CART Cell Injection in Patients With R/R Acute B-lymphoblastic Leukemia
NCT06307600B Lymphoblastic Leukemia/Lymphoma
Anhui Provincial Hospital
Phase EARLY_PHASE1
9
Hefei, Wuhan
2024-03-15
Active, closed
Effect of Stem Cell Infusion Time on aGVHD in Patients With Hematological Malignancies
NCT06294678Acute Graft-versus-host Disease
Anhui Provincial Hospital
Phase 3
198
Hefei, Beijing, Zhengzhou, Wuhan, Shanghai, Hangzhou
2024-03-01
Recruiting
Short-course Hypofractionated Radiotherapy in Combination With Raltitrexed and Tislelizumab
NCT06408584Esophageal Squamous Cell Carcinoma
Anhui Provincial Hospital
Observational
25
Hefei
2024-03-01
Recruiting
A Trial to Evaluate the Safety and Preliminary Efficacy of iMesenchymal Stromal Cells(iMSC) in Subjects With SR-aGVHD
NCT06321198Steroid-refractory Acute Graft-versus-host Disease(SR-aGVHD)
Anhui Provincial Hospital
Not applicable
12
Hefei
2024-02-10
Recruiting
Neoadjuvant Chemoimmunotherapy Followed by Surgery and Postoperative Radioimmunotherapy
NCT06602843Esophageal Squamous Cell Carcinoma
Anhui Provincial Hospital
Not applicable
70
Hefei
2024-01-01
Recruiting
An Observational Study of Menopausal Symptom in Patients With Gynecological Malignancy After Oophorectomy
NCT06151028Gynecological Malignancies, Menopausal Symptoms, Bone Loss
Anhui Provincial Hospital
Observational
490
Hefei
2023-12-01
Active, closed
Observational, Bivariate Analysis of Clinical Big Data in Patients With Cervical Cancer
NCT06480617Progression-free Survival Was Defined From Date of Surgery to Disease Progression Post-surgery or Death or Last Follow-up, Overall Survival Was Defined as Time From Surgery to Death From Any Cause or Last Follow-up
Anhui Provincial Hospital
Observational
3,000
Hefei
2023-10-31
Recruiting
Postoperative Radiotherapy Followed by Immunotherapy for Locally Advanced Esophageal Carcinoma
NCT05937438Esophageal Carcinoma
Anhui Provincial Hospital
Phase 1/2
70
Hefei
2023-09-01
Recruiting
Whole-course Immunonutrition Combined With ChemoradiotherapyยฑICIs for Local Advanced Patients With Inoperable Esophageal Squamous Cell Carcinoma
NCT05833594Esophageal Squamous Cell Carcinoma, Chemoradiotherapy, Immunonutrition, Inoperable
Anhui Provincial Hospital
Observational
70
Hefei
2023-07-01
Recruiting
Avatrombopag for Platelet Recovery Post-UCBT in Patients With Bone Marrow Failure Disease
NCT05823376Platelet Recovery After Umbilical Cord Blood Transplantation
Anhui Provincial Hospital
Observational
40
Hefei
2023-05-04
Recruiting
Liver Volume Metrics for Predicting Immunotherapy Prognosis in Unresectable Hepatocellular Carcinoma
NCT07782632Hepatocellular Carcinoma (HCC)
Anhui Provincial Hospital
Observational
467
Hefei
2019-01-01
Recruiting
Multimodal Survival Prediction Model for Colorectal Liver Metastases Post-Operation
NCT07830576Colorectal Liver Metastases, Colorectal Neoplasms, Liver Neoplasms
Anhui Provincial Hospital
Observational
205
Hefei
2017-02-01
Rows per page Showing 1–55 of 55
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china/city/hefei

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 55 of those studies with a site in Hefei that also match the filters currently applied.

How many clinical trials are recruiting in Hefei?

43 of the 55 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 8 have not yet opened recruitment, 3 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Hefei), 55 studies
PhaseStudiesRecruitingShare
Observational191534.5%
Phase 210818.2%
Not applicable9816.4%
Phase 1529.1%
Phase EARLY_PHASE1559.1%
Phase 3325.5%
Phase 1/2223.6%
Phase 4213.6%

Most active sponsors

Lead sponsors with the most studies (Hefei)
Lead sponsorStudiesRecruiting
Anhui Provincial Hospital5543
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.